Compare AMLX & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | TRMD |
|---|---|---|
| Founded | 2014 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.5B |
| IPO Year | 2021 | 2016 |
| Metric | AMLX | TRMD |
|---|---|---|
| Price | $29.85 | $35.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $21.56 | ★ $35.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 6.61% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $10.83 | $19.30 |
| 52 Week High | $41.14 | $38.73 |
| Indicator | AMLX | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 57.53 |
| Support Level | $12.54 | $28.19 |
| Resistance Level | $34.35 | $38.73 |
| Average True Range (ATR) | 1.56 | 1.29 |
| MACD | -0.83 | -0.28 |
| Stochastic Oscillator | 18.79 | 49.21 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
TORM PLC operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha, and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.